About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Telemedicine & COVID-19: Are There Limitations? Does it Disrupt the Ritualization of Doctor/Patient Visits, and the Ability to Assess the Patient?
By
GRACE
FEATURING
Jack West
,
Jared Weiss
,
Benjamin Levy
By
GRACE
FEATURING
Jack West
,
Jared Weiss
,
Benjamin Levy
51 views
April 23, 2020
1 Comment
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
04:32
Stanford Medicine
DEA Guidelines for Prescribing During COVID-19: How Do You Continue …
Feat.
S. Pritzlaff
13:03
Stanford Medicine
COVID-19 Pain Management Best Practices: How to Prioritize Procedure…
Feat.
S. Pritzlaff,
M. Leong,
R. Prasad
06:39
University of Miami Sylvester Comprehensive Cancer Center
COVID-19 Pandemic: Preparation Protocols, Telemedicine, and Modifyin…
Feat.
G. Lopes
15:15
Penn Medicine Abramson Cancer Center
Update on Treatment and Prevention of COVID-19 in Cancer Patients
Feat.
A. Garfall
16:52
AstraZeneca Oncology
Prioritizing Early Diagnosis of Lung Cancer and Challenges During th…
Feat.
N. Hanna,
M. Pritchett
15:41
ERIC 2022 - European Research Initiative on CLL - ERIC
Outcomes of Patients With CLL and COVID-19 Infection
Feat.
T. Chatzikonstantinou
33:56
Indy Hematology Review
Non-Malignant Hematology: What Have We Learned in 2022
Feat.
C. Kessler
09:06
James Bussel
COVID-19, Thrombocytopenia & ITP: What is the Effect on Platelet…
20:35
Total Health
Lung Cancer and COVID-19 Updates
Feat.
S. Richey
10:12
Memorial Sloan Kettering Cancer Center
Perspectives on COVID-19 and Multiple Myeloma Care: New York City, E…
Feat.
O. Landgren
09:57
ASCO 2022 Conference Coverage
ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…
Feat.
C. Dang
08:38
ASH 2021 Conference Coverage on VuMedi
ASH 2021 Clinical Predictors of Outcomes in Adult Acute Leukemias an…
Feat.
P. Desai
21:57
Platelet Disorder Support Association (PDSA)
COVID-19 & ITP Updates
Feat.
T. Gernsheimer
37:56
ASH 2022 Conference Coverage
Updates on Thrombosis & COVID-19
Feat.
B. Hunt
36:00
Stanford Medicine
SARS-CoV-2 & ASCO Guidelines: Are Pts With Cancer More Likely to…
Feat.
V. Agarwala
74:14
AstraZeneca Oncology
Lung Cancer Diagnosis and Patient Management During the COVID-19 Pan…
Feat.
D. Hogarth,
G. Cumbo-Nacheli,
G. T Lam,
A. Moriarity
68:24
AstraZeneca Oncology
Continuing Lung Cancer Diagnosis, Workup, & Care Across the Spec…
Feat.
G. Cumbo-Nacheli,
J. Gorden,
B. Stiles
20:08
2022 West Oncology Conference
2022 West Oncology Conference Updates on Cancer and COVID-19: What D…
Feat.
S. Richey
27:30
Ify Osunkwo
Pearls for Providers on Managing Sickle Cell Disease and COVID-19: W…
14:29
Total Health
Cancer Care & COVID19: Which Cancer Pts & Which Regimens Are…
Feat.
M. Pegram
